![](https://cancer.uillinois.edu/wp-content/uploads/2022/05/Feldman-Onclive-5-23-22.png)
Cancer Center Member Lawrence E. Feldman, MD, discusses the phase 3 LEAP-006 trial evaluating lenvatinib and pembrolizumab plus chemotherapy in non–small cell lung cancer.
![](https://cancer.uillinois.edu/wp-content/uploads/2021/08/OncLive_2013_SAP_Seal.jpg)
The University of Illinois Cancer Center serves as a Strategic Alliance Partner with OncLive. View our complete video library.